Triple therapy in a single inhaler: a new option for uncontrolled asthma.

Richard H. Stanford, Alicia W. Gilsenan, Ryan Ziemiecki, Xiaolei Zhou, William R. Lincourt, Hector Ortega, Predictors of uncontrolled asthma in adult and pediatric patients: analysis of the Asthma Control Characteristics and Prevalence Survey Studies (ACCESS). Journal of Asthma. ,vol. 47, pp. 257- 262 ,(2010) , 10.3109/02770900903584019

Elisabeth H. Bel, Sally E. Wenzel, Philip J. Thompson, Charlene M. Prazma, Oliver N. Keene, Steven W. Yancey, Hector G. Ortega, Ian D. Pavord, Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma The New England Journal of Medicine. ,vol. 371, pp. 1189- 1197 ,(2014) , 10.1056/NEJMOA1403291

Huib A.M. Kerstjens, Michael Engel, Ronald Dahl, Pierluigi Paggiaro, Ekkehard Beck, Mark Vandewalker, Ralf Sigmund, Wolfgang Seibold, Petra Moroni-Zentgraf, Eric D. Bateman, Tiotropium in Asthma Poorly Controlled with Standard Combination Therapy The New England Journal of Medicine. ,vol. 367, pp. 1198- 1207 ,(2012) , 10.1056/NEJMOA1208606

Eric D. Bateman, Homer A. Boushey, Jean Bousquet, William W. Busse, Tim J. H. Clark, Romain A. Pauwels, Søren E. Pedersen, Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. American Journal of Respiratory and Critical Care Medicine. ,vol. 170, pp. 836- 844 ,(2004) , 10.1164/RCCM.200401-033OC

Eric D. Bateman, Dirk Esser, Costel Chirila, Maria Fernandez, Andy Fowler, Petra Moroni-Zentgraf, J. Mark FitzGerald, Magnitude of effect of asthma treatments on Asthma Quality of Life Questionnaire and Asthma Control Questionnaire scores: Systematic review and network meta-analysis The Journal of Allergy and Clinical Immunology. ,vol. 136, pp. 914- 922 ,(2015) , 10.1016/J.JACI.2015.03.023

Philippa Ellwood, Monica Innes Asher, The Global Asthma Report 2014 Global Asthma Network 2014. ,(2014)

J Mark FitzGerald, Eugene R Bleecker, Parameswaran Nair, Stephanie Korn, Ken Ohta, Marek Lommatzsch, Gary T Ferguson, William W Busse, Peter Barker, Stephanie Sproule, Geoffrey Gilmartin, Viktoria Werkström, Magnus Aurivillius, Mitchell Goldman, Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial The Lancet. ,vol. 388, pp. 2128- 2141 ,(2016) , 10.1016/S0140-6736(16)31322-8

J Mark FitzGerald, Eugene R Bleecker, Andrew Menzies-Gow, James G Zangrilli, Ian Hirsch, Paul Metcalfe, Paul Newbold, Mitchell Goldman, Predictors of enhanced response with benralizumab for patients with severe asthma: pooled analysis of the SIROCCO and CALIMA studies. The Lancet Respiratory Medicine. ,vol. 6, pp. 51- 64 ,(2018) , 10.1016/S2213-2600(17)30344-2

Mario Castro, Jonathan Corren, Ian D. Pavord, Jorge Maspero, Sally Wenzel, Klaus F. Rabe, William W. Busse, Linda Ford, Lawrence Sher, J. Mark FitzGerald, Constance Katelaris, Yuji Tohda, Bingzhi Zhang, Heribert Staudinger, Gianluca Pirozzi, Nikhil Amin, Marcella Ruddy, Bolanle Akinlade, Asif Khan, Jingdong Chao, Renata Martincova, Neil M.H. Graham, Jennifer D. Hamilton, Brian N. Swanson, Neil Stahl, George D. Yancopoulos, Ariel Teper, Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma The New England Journal of Medicine. ,vol. 378, pp. 2486- 2496 ,(2018) , 10.1056/NEJMOA1804092

Johann Christian Virchow, Piotr Kuna, Pierluigi Paggiaro, Alberto Papi, Dave Singh, Sandrine Corre, Florence Zuccaro, Andrea Vele, Maxim Kots, George Georges, Stefano Petruzzelli, Giorgio Walter Canonica, None, Single inhaler extrafine triple therapy in uncontrolled asthma (TRIMARAN and TRIGGER): two double-blind, parallel-group, randomised, controlled phase 3 trials The Lancet. ,vol. 394, pp. 1737- 1749 ,(2019) , 10.1016/S0140-6736(19)32215-9